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Linker for activation of T cells (LAT) is a scaffolding adaptor protein that is critical for T cell 
development and function. A mutation of LAT (Y136F) that disrupts phospholipase C-
 
 
 
1 
activation and subsequent calcium influx causes a partial block in T cell development and 
leads to a severe lymphoproliferative disease in homozygous knock-in mice. One possible 
contribution to the fatal disease of LAT Y136F knock-in mice could be from autoreactive 
T cells generated in these mice because of altered thymocyte selection. To examine the 
impact of the LAT Y136F mutation on thymocyte positive and negative selection, we bred 
this mutation onto the HY T cell receptor (TCR) transgenic, recombination activating 
gene-2 knockout background. Female mice with this genotype showed a severe defect in 
positive selection, whereas male mice exhibited a phenotype resembling positive selection 
(i.e., development and survival of CD8
 
hi 
 
HY TCR-specific T cells) instead of negative selection. 
These results support the hypothesis that in non-TCR transgenic, LAT Y136F knock-in mice, 
altered thymocyte selection leads to the survival and proliferation of autoreactive T cells 
that would otherwise be negatively selected in the thymus.
 
The mature T cell repertoire contains a very
large number of TCRs with the potential to
bind foreign antigens with high affinity, but it
is relatively devoid of TCRs that bind with
high affinity to self-peptides. Positive selection
accounts for survival and proliferation of T cells
that are minimally reactive to self but poten-
tially highly reactive to foreign antigens, whereas
negative selection functions to eliminate (by
programmed cell death) overtly autoreactive T
cells. A wealth of information, some of it con-
flicting, has accumulated concerning what signals
mediate positive and negative selection (for re-
view see references 1–3). In general, ligands
that induce weak TCR signaling and/or slow,
sustained Erk activation promote positive se-
lection, whereas ligands that induce strong
TCR signaling including strong, transient Erk
activation promote negative selection (3–5).
Under these circumstances, quantitative differ-
ences in signaling account for the outcome of
selection. Qualitative differences in signaling
have also been suggested to contribute to the
outcome of selection. For example, signaling
through Ras/Raf/Mek/Erk pathways has been
described to impact positive but not negative
selection (2). Furthermore, differential contri-
butions from phospholipase C (PLC)-
 
 
 
1, Erk,
p38, and Jnk signaling pathways may collec-
tively determine the outcome of selection (1).
Linker for activation of T cells (LAT) is an
adaptor protein that is critical for T cell signaling
and T cell development (for review see refer-
ences 6 and 7). LAT contains nine conserved ty-
rosines in its cytoplasmic domain, the distal four
of which are absolutely required for both TCR
signaling and T cell development (8–12). Tyro-
sine 136 (Y136) of mouse LAT is a docking site
for PLC-
 
 
 
1. The other three distal tyrosines of
LAT bind the adaptor proteins Grb-2 and Gads
and likely other molecules. Grb-2 can associate
with the Ras GEF Sos and the ubiquitin ligase
and adaptor protein Cbl. Gads associates with
the adaptor SLP-76, which can stimulate actin
remodeling through interactions with Vav and
Nck (13). In addition, SLP-76 associates directly
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with PLC-
 
 
 
1 and may participate in PLC-
 
 
 
1 activation by re-
cruiting the Tec family tyrosine kinase Itk (14, 15). PLC-
 
 
 
1
activation results in Ca
 
2
 
  
 
release, which in turn activates the
calcium-dependent phosphatase calcineurin. Calcineurin acti-
vation then results in activation of transcription factors for cy-
tokine genes, resulting in T cell proliferation (16). Ras can
potentially be stimulated by at least two LAT-dependent path-
ways: first, by association of Sos with LAT-associated Grb-2,
and second, by PLC-
 
 
 
1–mediated production of diacylglycerol,
which activates the Ras GEF, RasGRP (17, 18). Ras signaling
can then activate Erk and Jnk kinases. Coordinated activation
of both calcium and Ras signaling pathways are thought to be
required for full T cell activation and might be required for ef-
ficient thymocyte selection as well (19).
We and others have generated knock-in mice to study
contributions of individual tyrosines of LAT to signal trans-
duction and T cell development (20, 21). Mutation of Y136
(the PLC-
 
 
 
1–binding tyrosine residue of LAT) results in a
partial block in early T cell development. However, begin-
ning at about weaning age, a fatal lymphoproliferative dis-
ease characterized by expansion of Th2 cell–type CD4
 
  
 
cells
ensues. Interestingly, TCR-mediated calcium mobilization
in LAT Y136 knock-in T cells is drastically reduced, al-
though TCR-induced Erk signaling is relatively intact.
Therefore, LAT Y136 knock-in mice provide a useful sys-
tem for assessing the effects of selectively disrupting PLC-
 
 
 
1
activation in developing T cells. In this study, we interbred
LAT Y136 knock-in mice and TCR transgenic mice to ana-
lyze the effect of disrupting calcium signaling on thymocyte
selection in an in vivo model using endogenous ligands. The
HY TCR transgenic system was chosen as a well-established
TCR transgenic system whose TCR binds to a male-specific
peptide allowing analysis of both positive and negative selec-
tion using female and male mice, respectively (22). Using
this system, we demonstrate that both positive and negative
selection are altered by the LAT Y136F mutation. A possible
consequence of altered negative selection in LAT Y136F
knock-in mice is survival and proliferation of autoreactive T
cells that contribute to the fatal lymphoproliferative disease
that develops in these mutant mice.
 
RESULTS
The lymphoproliferative disorder in LATY136F
 
m/m 
 
mice is not 
abrogated by introduction of a TCR transgene
 
We and others previously described the phenotype of LAT
knock-in mice in which tyrosine 136, a consensus binding
Figure 1. LAT Y136F phenotype is dominant in HY  LAT Y136Fm/m 
female and male mice. (a) Thymocytes and lymph node cells from HY  
LAT /  and HY  LAT Y136Fm/m female mice were analyzed by flow cytometry 
using anti-CD4, anti-CD8, and T3.70 antibodies. CD4 versus CD8 dot plots 
are shown either ungated or gated on T3.70hi cells. HY  LAT /  and HY  
LAT Y136Fm/m female mice were 41 and 8 wk of age, respectively. (b) Thy-
mocytes and lymph node cells from HY  LAT /  and HY  LAT Y136Fm/m 
male mice were analyzed as described in (a). HY  LAT /  and HY  LAT 
Y136Fm/m male mice were 7 wk of age. (c) Thymocytes and lymph node cells 
from a LAT Y136Fm/m mouse (5 wk old) were analyzed as described in (a). 
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site for PLC-
 
 
 
1, is mutated to phenylalanine (20, 21). In
brief, LAT Y136F
 
m/m 
 
mice exhibit a severe block in thy-
mocyte development that is best documented early in life.
Thymi from these mice are small and contain mostly CD4
 
 
 
CD8
 
  
 
(double negative [DN]) thymocytes. The block is at
the DN3 (CD25
 
  
 
CD44
 
 
 
) stage, confirming a requirement
for wild-type LAT for pre-TCR signaling. As they age, vir-
tually all LAT Y136F
 
m/m 
 
mice develop a lymphoproliferative
disease evidenced by markedly enlarged spleens and lymph
nodes and lymphocytic infiltration of multiple organs. T cells
in LAT Y136F
 
m/m 
 
mice arise from polyclonal expansion and
consist almost entirely of CD4
 
  
 
CD3
 
lo 
 
CD62L
 
lo 
 
CD44
 
hi 
 
cells,
thus showing signs of previous activation. Thymocytes and
T cells from LAT Y136F
 
m/m 
 
mice are defective in TCR-
induced calcium flux, but have near normal levels of Erk ac-
tivation. To assess the effect of this relatively specific defect
in calcium signaling on positive and negative selection, the
LAT knock-in mutants were interbred with HY TCR trans-
genic mice. The HY TCR transgene was chosen because
the HY TCR reacts with the male-specific antigen HY,
causing negative selection in male mice; however, in female
HY TCR transgenic mice, T cells are positively selected by
endogenous peptide(s) (22). Therefore, use of the HY model
system allows us to analyze both positive and negative selec-
tion in one TCR transgenic system and to investigate if class
I–restricted LAT mutant T cells would exhibit a similar phe-
notype to LAT Y136F CD4
 
  
 
T cells. As shown in Fig. 1,
HY
 
  
 
LAT Y136F
 
m/m 
 
males and females exhibited a pheno-
type essentially identical to LAT Y136F
 
m/m 
 
mice. They also
had enlarged spleens and lymph nodes (not depicted). Thymi
from the mutant mice displayed varying degrees of infiltra-
tion by CD4
 
  
 
CD3
 
lo 
 
CD62L
 
lo 
 
CD44
 
hi 
 
T cells, characteristic
of peripheral T cells seen in non-TCR transgenic LAT
knock-in mice. These infiltrating peripheral T cells were the
only T cells found in the thymus later in life (after 
 
 
 
2 mo of
age; not depicted). Lymph node T cells were largely CD4
 
 
 
(i.e., they were not MHC class I restricted) and did not stain
with antibody to the HY transgenic TCR (T3.70). In con-
trast, female control HY
 
  
 
LAT
 
 
 
/
 
  
 
mice contained T3.70
 
 
 
CD8
 
hi 
 
cells in the periphery, a result of successful positive se-
lection of transgenic T cells (Fig. 1). Male control HY
 
 
 
LAT
 
 
 
/
 
  
 
mice lacked T3.70
 
  
 
CD8
 
hi 
 
T cells in the periphery,
but had T3.70
 
  
 
CD8
 
lo 
 
transgenic T cells, which have been
described previously (22).
To investigate if the LATY136F
 
m/m 
 
lymphoproliferative
phenotype would also manifest in other TCR transgenic
mouse model systems, we interbred the LAT knock-in mu-
tant with class II–restricted AND TCR transgenic mice (23).
Figure 2. Positive selection in HY  LAT Y136Fm/m RAG-2 knockout 
female mice. (a) Thymocytes from HY  LAT /  RAG-2 /  and HY  LAT 
Y136Fm/m RAG-2 /  female mice were analyzed as described in Fig. 1. Total 
thymocyte numbers are given in parentheses. Unfilled histograms repre-
sent nonspecific antibody controls. HY  LAT /  RAG-2 /  and HY  LAT 
Y136Fm/m RAG-2 /  female mice were 22 and 4 wk of age, respectively. 
(b) Lymph node cells from HY  LAT /  RAG-2 /  and HY  LAT Y136Fm/m 
RAG-2 /  female mice were analyzed as described in (a). 
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A similar phenotype was observed, i.e., expansion of CD4
 
 
 
T cells not staining for the transgenic TCR (V
 
 
 
11
 
 
 
) and the
presence of large lymph nodes and spleens (not depicted).
We speculated that either the LAT Y136F mutation drives
all T cells to the same phenotype regardless of the TCR that
they express, or that the specificity of the TCRs in these
TCR transgenic model systems was changed by the pairing
of transgenic TCR
 
  
 
chains with endogenous TCR
 
  
 
chains,
a phenomenon known to occur due to incomplete early al-
lelic exclusion of the TCR
 
  
 
locus (24). To distinguish be-
tween these possibilities, we examined the HY TCR trans-
genic system in more detail by crossing the LAT mutation
onto the RAG knockout background, where TCR specific-
ity would be fixed because contributions from endogenous
TCR
 
  
 
chains would be eliminated.
 
Lack of positive selection in HY
 
  
 
LATY136F
 
m/m 
 
RAG
 
 /  
female mice
By breeding onto the RAG-2 null background, we were
able to determine whether clonotypic CD8hi T cells could
develop in HY  LAT Y136F knock-in mice by preventing
expression of endogenous TCR   or    chains, therefore
eliminating competition from CD4  T cells expressing en-
dogenous TCR  chains. A much different phenotype was
Figure 3. Negative selection in HY  LAT Y136Fm/m RAG-2 knockout 
male mice. (a) Thymocytes from HY  LAT /  RAG-2 /  and HY  LAT 
Y136Fm/m RAG-2 /  male mice were analyzed as described in Fig. 1. Thy-
mocytes from HY  LAT /  RAG-2 /  female mice are shown for compari-
son. Total thymocyte numbers are given in parentheses. HY  LAT /  
RAG-2 /  female, HY  LAT /  RAG-2 /  male, and HY  LAT Y136Fm/m 
RAG-2 /  male mice were 24, 11, and 21 wk of age, respectively. (b) Lymph 
node cells from HY  LAT /  RAG-2 /  and HY  LAT Y136Fm/m RAG-2 /  
male mice were analyzed as described in (a).JEM VOL. 201, April 4, 2005 1129
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observed using the RAG-2 null background. In HY  LAT
Y136Fm/m RAG-2 /  female mice, thymi were smaller than
those in their LAT /  counterparts, about one fifth to one
tenth the normal size (Fig. 2 a). This decrease in thymic cel-
lularity, especially in the number of CD4  CD8  (double
positive [DP]) thymocytes is consistent with a block in the
DN→DP transition (20). Although DP thymocytes are gen-
erated, a distinct population of CD8 single positive (SP) thy-
mocytes is missing, indicating a defect in positive selection.
DPs from HY  LAT Y136Fm/m RAG-2 /  female mice ex-
press lower levels of the HY transgenic TCR as evidenced
by staining with the antibody T3.70 ( 60% wild-type lev-
els). Consistent with a lack of positive selection in the thy-
mus, HY  LAT Y136Fm/m RAG-2 /  female mice do not
contain T3.70hi CD8hi T cells in the periphery (Fig. 2 b).
Impaired negative selection in male HY  LAT Y136Fm/m mice
Because of the extensive negative selection of HY clono-
typic T cells in male HY  LAT /  mice, thymi are small and
contain mostly DN thymocytes (Fig. 3 a). In HY  LAT
Y136Fm/m RAG-2 /  male mice, thymi are also small; how-
ever, T3.70hi DP and CD8 SP are evident, much like in
HY  LAT /  RAG-2 /  female mice (Fig. 3 a), indicating a
failure of negative selection and possible conversion to posi-
tive selection. In the lymph nodes of HY  LAT Y136Fm/m
RAG-2 /  male mice, T3.70  CD8hi T cells are evident,
again suggesting a failure of negative selection and possible
conversion to positive selection (Fig. 3 b). In HY  LAT / 
RAG-2 /  male mice, T3.70  DN and CD8lo T cells are
also observed. These T cells have been hypothesized to be
aberrant populations from the     T cell lineage (25). In
HY  LAT Y136Fm/m RAG-2 /  male mice, these popula-
tions are not present.
A possible contribution to the lack of negative selection
in HY  LAT Y136Fm/m RAG-2 /  male mice could derive
from defects in activation-induced cell death in DP thy-
mocytes. Plate-bound T3.70 and anti-CD28 were used to
mimic signals known to induce cell death in DP thymocytes
(26). DP thymocytes from HY  LAT /  RAG-2 /  female
mice showed an increase from 22 to 79% annexin V  under
these antibody stimulation conditions (Table I). However,
DP thymocytes from HY  LATm/m RAG-2 /  male mice
showed no increase in the percentage of annexin V  T cells
under these antibody stimulation conditions. As a control,
etoposide treatment resulted in 100% annexin V  DPs in
both HY  LAT /  RAG-2 /  female and HY  LAT Y136Fm/m
RAG-2 /  male mice.
We also tested the response of DP thymocytes from
HY  LAT Y136Fm/m RAG-2 /  female mice to antibody
stimulation. DP thymocytes from HY   LAT Y136Fm/m
RAG-2 /  females showed no increase in annexin V stain-
ing in response to T3.70 and anti-CD28 treatment. In addi-
tion, incubation with HY peptide-loaded APCs did not re-
sult in increased annexin V staining above APC controls in
the mutants, whereas DP thymocytes from HY  LAT / 
RAG-2 /  female mice did have increased annexin V stain-
ing. Again, etoposide treatment resulted in high rates of cell
death in both HY   LAT /   RAG-2 /   and HY   LAT
Y136Fm/m RAG-2 /  female mice. These data indicate a
failure of TCR-mediated induction of cell death in thy-
mocytes from both male and female mutant mice.
Biochemical characterization of T cells from male 
HY  LAT Y136Fm/m mice
Because defects in TCR-induced calcium influx were de-
scribed in thymocytes and peripheral T cells from LAT
Y136Fm/m mice (20), we also measured calcium influx in T cells
from HY  LAT Y136Fm/m RAG-2 /  mice. DP thymocytes
and CD8  lymph node T cells from HY  LAT Y136Fm/m
RAG-2 /  male mice had reduced TCR-induced calcium in-
flux compared with DP thymocytes and CD8  lymph node T
cells from C57BL/6 and HY  LAT /  RAG-2 /  female mice
(Fig. 4 a). DP thymocytes from HY  LAT Y136Fm/m RAG-
2 /  female mice also had diminished levels of calcium influx
compared with DP thymocytes from C57BL/6 and HY 
LAT /  RAG-2 /  female mice (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20041869/DC1). How-
ever, initial calcium influx in DP thymocytes from HY  LAT
Y136Fm/m RAG-2 /  male and female mice and in CD8 
lymph node T cells from HY  LAT Y136Fm/m RAG-2 / 
male mice was higher than in DP thymocytes and CD4  lymph
node T cells from non-TCR transgenic LAT Y136F knock-in
Table I. Activation-induced cell death is defective in HY  LATY136Fm/m RAG-2 knockout male and female thymocytes
Percent of annexin V  DP thymocytes
Control T3.70  CD28 APC control APC HY peptide VP16
HY  LAT    RAG    femalea 22 79 ndb nd 100
HY  LATY136Fm/m RAG    malea 39 40 nd nd 100
HY  LAT    RAG    femalec 31 90 68 91 99
HY  LATY136Fm/m RAG    femalec 38 22 66 58 99
Thymocytes from HY  LATY136Fm/m RAG    male and HY  LATY136Fm/m RAG    female mice were stimulated with 5 ug/ml plate-bound T3.70 and 50 ug/ml anti-CD28 or APCs 
preloaded with 1 uM HY peptide. As a positive control for apoptosis, thymocytes were also treated with etoposide (VP16). Annexin V staining was determined by flow cytometry 
after 24 h of incubation.
aExperiment 1.
bNot done.
cExperiment 2.LAT MUTATION AFFECTS POSITIVE AND NEGATIVE SELECTION | Sommers et al. 1130
mice (Fig. 4 a and Fig. S1). This heightened initial calcium in-
flux could be characteristic of the strength of signal from the
HY TCR (compared with the diversity of TCRs found in T
cells in LAT Y136F knock-in mice) or due to the higher levels
of TCR in HY  LAT Y136Fm/m RAG-2 /  T cells compared
with non-TCR transgenic LAT Y136Fm/m T cells. In the case
of peripheral cells, the difference could also be related to differ-
ences between CD4  and CD8  T cells. We were unable to
obtain data for TCR-induced calcium influx in CD8  T cells
from LAT Y136F knock-in mice to make a direct comparison
because so few of those cells exist.
We also examined Erk activation in T cells from HY 
LAT Y136Fm/m RAG-2 /  mice by measuring levels of phos-
pho-Erk1/2 by flow cytometry. The extent and kinetics of
Erk activation was approximately the same in DP thymocytes
(Fig. 4 b) and CD8  lymph node T cells (not depicted) from
HY  LAT Y136Fm/m RAG-2 /  male mice and HY  LAT / 
RAG-2 /  female mice. Erk activation in HY  LAT
Y136Fm/m RAG-2 /  female DP thymocytes was observed,
although the increase in phospho-Erk levels at 1 min of TCR
activation was less pronounced in mutant female (1.4-fold in-
crease) than in mutant male thymocytes (2.2-fold increase).
This may reflect differences in levels of ongoing positive se-
lection in the male and female mutant mice. The increase in
phospho-Erk staining in male mutant thymocytes at 1 min of
activation was similar to that seen in HY  LAT /  RAG-2 / 
female thymocytes (2.4-fold). These results are consistent
with the small impact of the LAT Y136F mutation on Erk ac-
tivation in T cells from LAT Y136F non-TCR transgenic
mice as observed previously (20).
Evidence of conversion of negative selection to positive 
selection in male HY  LAT Y136Fm/m mice
To examine the differentiation state of CD8 SP thymocytes
and CD8  lymphocytes from HY  LAT Y136Fm/m RAG-
2 /  mice, we measured the expression of several cell surface
markers by flow cytometry (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20041869/DC1). Thy-
mocyte maturation is accompanied by down-regulation of
CD24 (HSA) and, in the CD8 lineage, up-regulation of  7
integrin (27, 28). CD24 is down-regulated and  7 integrin is
up-regulated in mature T cells from HY  LAT Y136Fm/m
RAG-2 /  male mice as in mature T cells from HY  LAT / 
RAG-2 /  female mice. CD69, a marker of maturation and
activation, is up-regulated in CD8 SP thymocytes compared
with DP thymocytes from both kinds of mice and, in fact, is
up-regulated to a slightly greater extent in the mutant male
mice, consistent with functional activation of the Ras/Erk
pathway in these mice (29). TCR (T3.70) levels are consis-
tently lower in T cells from the male mutant mice than in
female wild-type mice.
To investigate whether bona fide CD8  T cells develop
in HY  LAT Y136Fm/m RAG-2 /  male mice by positive
selection, we analyzed the expression of perforin, a differen-
tiation marker of CD8  cytotoxic T cells. CD8 SP thy-
mocytes were sorted and analyzed by RT-PCR for expres-
sion of perforin. As shown in Fig. 5, CD8 SP thymocytes
from HY  LAT Y136Fm/m RAG-2 /  male mice (as well as
from HY  LAT /  RAG-2 /  female mice and control
C57BL/6 mice) expressed perforin. Perforin expression was
also detected by RT-PCR in CD8  splenocytes from these
mice (not depicted).
Figure 4. TCR-induced calcium flux and Erk activation in T cells 
from HY  LATm/m RAG-2 /  male mice. (a) TCR-induced calcium flux of 
CD4  CD8  thymocytes (top) or CD8  lymph node cells (bottom) was mea-
sured as described in Materials and methods. T cells were from C57BL/6 
(dark blue), LAT Y136Fm/m (pink), HY  LAT /  RAG-2 /  female (yellow) or 
HY  LATm/m RAG-2 /  male mice (light blue). For LAT Y136Fm/m mice, T cells 
were stimulated with anti-CD3 and anti-CD4 (instead of anti-CD8), and 
CD4  lymph node cells are pictured in the bottom instead of CD8  lymph 
node cells because there are only very few CD8  peripheral T cells in LAT 
Y136Fm/m mice. Antibodies (A; anti-CD3 and anti-CD8 or anti-CD3 and 
anti-CD4 in the case of LAT Y136Fm/m mice) were added at 30 s and 
streptavidin (S) was added at 1 min. Cells were analyzed for a total of 7 
min. (b) Thymocytes from HY  LAT Y136Fm/m RAG-2 /  male and female 
mice and HY  LAT /  RAG-2 /  female mice were analyzed for levels of 
phospho-Erk by flow cytometry as described in Materials and methods. 
Data are shown for Thy1.2  CD4  (DP) thymocytes. Histograms represent 
unstimulated T cells (filled gray), anti-CD3 and anti-CD8 stimulation for 1 
min (green), and anti-CD3 and anti-CD8 stimulation for 5 min (blue).JEM VOL. 201, April 4, 2005 1131
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To investigate whether CD8  T cells in HY  LAT
Y136Fm/m RAG-2 /  male mice were functional (as might
be expected if they resulted from normal positive selection),
we examined the ability of peripheral CD8  T cells to pro-
liferate in response to TCR stimulation. Purified CD8  T
cells from HY  LAT Y136Fm/m RAG-2 /  male mice did
not proliferate in response to antibody stimulation or treat-
ment with HY peptide-loaded APCs as did CD8  T cells
from HY  LAT /  RAG-2 /  female mice (Fig. 6). Even
use of high concentrations of antibodies or HY peptide for
stimulation did not result in a proliferative response in CD8 
T cells from HY  LAT Y136Fm/m RAG-2 /  male mice
(not depicted). Because this proliferation defect could be due
to the effects of the LAT Y136F mutation, we included ion-
omycin in an attempt to bypass the PLC- 1–mediated Ca2 
defect in these cells. When ionomycin was included in cul-
tures with CD8  T cells from HY  LAT Y136Fm/m RAG-
2 /  male mice and HY peptide-loaded APCs, proliferation
did occur (Fig. 6). Ionomycin alone did not induce prolifer-
ation (not depicted). Therefore, mutant cells were able to re-
spond to antigen if calcium influx was pharmacologically in-
duced. Under the same conditions, however, interferon  
and IL-2 could not be detected from supernatants of cultures
of HY  LAT Y136Fm/m RAG-2 /  male CD8  T cells and
HY peptide-loaded APCs, even in the presence of ionomy-
cin, whereas cytokine secretion was detected after treatment
with PMA and ionomycin (not depicted). This suggests that
although CD8  T cells from mutant male mice can respond
to antigen, they are not fully functional in vivo, possibly due
to defects caused by the LAT Y136F mutation.
DISCUSSION
The LAT Y136F mutation impairs TCR-mediated PLC- 1
activation in thymocytes and T cells resulting in decreased
TCR-induced calcium influx (20, 21). We used this LAT
mutant to investigate the effect of dampening calcium signal-
ing on thymocyte positive and negative selection in a system
that does not use broad-range inhibitors of calcium-depen-
dent enzymes or agents that alter calcium influx triggered by
non-LAT–mediated signaling pathways. We examined HY
TCR transgenic, RAG-2 knockout mice to evaluate the ef-
fect of the LAT Y136F mutation on positive and negative
selection. In HY female mice, thymocytes normally undergo
positive selection resulting in the generation of HY TCR-
specific CD8hi T cells; however, HY LAT mutant female
mice showed a complete absence of positive selection. In
HY LAT /  male mice, thymocytes undergo negative selec-
tion and HY TCR-specific CD8hi T cells are absent because
the HY antigen is male specific. In contrast, T cells from HY
LAT mutant male mice do not undergo negative selection,
but instead resemble positively selected T cells found in
LAT /  HY females. The effect of dampening calcium sig-
naling in this system can be interpreted according to a quan-
titative model of thymocyte differentiation in which very
low levels of TCR signal result in nonselection (also called
death by neglect), intermediate signals result in positive se-
lection, and strong signals result in negative selection. Ac-
cording to this model, the “window” for positive and nega-
tive selection has been shifted in the LAT mutant mice such
that thymocytes from male mice, which would otherwise
undergo negative selection, undergo positive selection (or a
process very much like positive selection), and thymocytes
Figure 5. Perforin and CD3  RT-PCR. Thymocytes from HY  LAT /  
RAG-2 /  female and HY  LAT Y136Fm/m male mice were sorted and ana-
lyzed by RT-PCR for expression of perforin and CD3 . C57BL/6 (B6) thy-
mocytes are included for comparison.
Figure 6. In vitro proliferation of CD8  lymph node T cells from 
HY  LAT Y136Fm/m RAG-2 knockout male mice. CD8  T cells were 
purified by magnetic bead separation from lymph node preparations from 
HY  LAT /  RAG-2 /  female and HY  LAT Y136Fm/m RAG-2 /  male mice. 
Cells were loaded with CFSE and stimulated with 5 ug/ml of plate-bound 
T3.70 and 50 ug/ml anti-CD28 or with APCs loaded with 1,000 nM HY 
peptide in the absence or presence of 1,300 nM ionomycin. After 18 h, 
cells were analyzed by flow cytometry. CFSE staining is shown gated on 
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from female mice, which would otherwise undergo positive
selection, most likely undergo death by neglect.
PLC- 1, whose activation is defective in LAT Y136F
knock-in mice, catalyzes the conversion of phosphatidyl-
inositol (4,5) bisphosphate to diacylglycerol and inositol
(1,4,5) trisphosphate. An increase in inositol (1,4,5) tris
phosphate levels results in release of calcium from intracellu-
lar stores, whereas increased diacylglycerol results in stimula-
tion of PKC and RasGRP (for review see reference 30).
Therefore, the effects on selection seen in this study could be
because of decreased signaling through PKC and RasGRP as
a result of decreased PLC- 1 activity. However, the down-
stream endpoint of Erk activation is relatively normal in
LAT Y136F mutant T cells, implying that Erk can be acti-
vated through mechanisms other than those mediated by
RasGRP in these cells. Pharmacologic disruptions of TCR-
mediated PLC- 1 signaling pathways have previously been
shown to affect thymocyte selection. Use of inhibitors that
block PKC (31) or of inhibitors of the calcium-dependent
phosphatase calcineurin (32) results in less thymocyte dele-
tion, an in vitro correlate of negative selection. Our results
are consistent with the idea that inhibition of downstream
mediators of PLC- 1 action can block negative selection.
Mutations in mice that alter PLC- 1–mediated signaling
have also been shown to affect positive and negative thy-
mocyte selection in ways consistent with results from this
study. A spontaneous mutation in ZAP-70, the kinase that
phosphorylates LAT, results in decreased LAT phosphoryla-
tion, decreased PLC- 1 phosphorylation, and decreased cal-
cium flux (33). Erk and p38 activities are also dampened.
When this mutation is crossed into the HY TCR transgenic
background, positive selection is abrogated in female mice,
and in male mice peripheral transgenic CD8  T cells are ob-
served, similar to the results observed here for the LAT
Y136F mutation (33). In addition, null mutation of TCR 
(which would preclude docking of ZAP-70 to the TCR
complex and prevent ZAP-70 activation) resulted in a pheno-
type resembling positive selection in male HY TCR trans-
genic mice and nonselection in female HY TCR transgenic
mice (34). The Tec family kinases Itk and Rlk/Txk regulate
PLC- 1 activity in T cells (15). Null mutation of both Itk and
Rlk/Txk results in decreased positive selection in HY female
mice and a phenotype suggestive of conversion of negative to
positive selection in HY male mice (35). Null mutation of Itk
and Rlk/Txk also resulted in decreased PLC- 1 activation,
decreased calcium flux, and dampened Erk activation (35).
Like the LAT Y136F mutation, all of these mutations de-
crease activation of PLC- 1 and activation-induced calcium
influx. Unlike the examples above, in HY LAT Y136F
knock-in mice, we were able to show antigen-induced prolif-
eration in peripheral CD8  male T cells by partially correcting
for the LAT mutant phenotype by treatment with the calcium
ionophore ionomycin, supporting the critical role of calcium
in thymocyte selection and T cell function.
We have speculated that the lymphoproliferative disease
in LAT Y136F knock-in mice could be due to expansion of
autoreactive T cells that have escaped negative selection
(20). A similar phenotype was observed in null mutants of
the calcium-regulated NFAT transcription family members
NFATc2 and NFATc3 (36, 37). NFAT transcription factors
are downstream targets of calcium-mediated TCR signaling.
Recent examples in the literature indicate that point muta-
tions in T cell signaling molecules could result in defects in
central (and not just peripheral) tolerance that could eventu-
ally lead to autoimmune disease. Examples of point muta-
tions in T cell signaling molecules leading to autoimmune
disease, presumably by failure of negative selection, include a
spontaneous mutation in the Rasgrp1 gene, which results in a
lymphoproliferative disease with symptoms resembling sys-
temic lupus erythematosus (38). Also, the ZAP-70 spontane-
ous mutant mentioned earlier (33) has a syndrome with
symptoms similar to autoimmune arthritis. A knock-in mu-
tation of the phosphatase CD45 (E613R) results in a lupus-
like nephritis (39). Possibly, mutations in different molecules
will skew the TCR repertoire in different ways, manifesting
as different autoimmune syndromes.
T cell hybridomas made from LAT Y136F peripheral T
cells were autoreactive as reported by Aguado et al. (21). In
this study, we have also provided evidence that aberrant
negative selection might be contributing to a skewed TCR
repertoire in LAT Y136F knock-in mice, which could ulti-
mately lead to proliferation of autoreactive T cells. This
conclusion is based on the fact that HY TCR  CD8hi T
cells can develop in LAT Y136Fm/m male mice. Lympho-
proliferative disease does not ensue, however, in the HY
model system, as evidenced by an absence of lymphadenop-
athy, splenomegaly, and lymphocytic infiltration to lung in
HY  LAT Y136Fm/m RAG-2 /  male mice (not depicted).
This absence of lymphoproliferative disease from HY 
LAT Y136Fm/m RAG-2 /  T cells could be because the
strength of signal transduced through the HY TCR may
not be sufficient to cause this response, or the HY (self-)
antigen may not be presented in the tissues examined. Al-
ternatively, the lymphoproliferative phenotype may only
manifest in CD4  MHC class II–restricted T cells. Future
experiments will be aimed at trying to distinguish between
these possibilities.
MATERIALS AND METHODS
Mice. LAT Y136F knock-in mice were described previously (20). HY
mice, which express an MHC class I–restricted TCR for the male antigen
HY (22), were obtained from NIAID Taconic exchange. RAG-2 knockout
mice were also obtained from NIAID Taconic exchange. All mice used in
this study were on a C57BL/6 (H-2Db) background and were housed un-
der specific pathogen-free conditions.
Flow cytometry. Single cell suspensions were analyzed by standard flow
cytometry as described previously (40). Flow cytometry was performed us-
ing a FACSCalibur and CELLQuest software (Becton Dickinson). Fluoro-
chrome-conjugated antibodies were purchased from BD Biosciences.
Thymocyte cell death assays. Thymocytes were harvested in Cellgro
complete serum-free medium (Mediatech), washed, and incubated with
plate-bound antibodies (5 ug/ml T3.70 and 50 ug/ml anti-CD28) or withJEM VOL. 201, April 4, 2005 1133
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APCs and HY peptide. APCs were prepared from ACK-treated splenocytes
by treatment with anti-Thy antibody followed by treatment with comple-
ment. The T cell–depleted splenocytes were then irradiated at 500 rads to
yield APCs. HY peptide (KCSRNRQYL) was synthesized by the FDA
core facility. Cells were harvested for flow cytometry after 18 h of incuba-
tion. Annexin V-FITC was purchased from BD Biosciences and was used
according to the manufacturer’s specifications.
Proliferation assays. CD8  T cells from lymph nodes were purified by
negative magnetic bead separation using biotinylated anti-B220, anti–Mac-1,
and anti-CD4 antibodies (BD Biosciences) as well as magnetic streptavi-
din beads (Miltenyi Biotec). Purified cells were loaded with CFSE (Molec-
ular Probes), washed, and incubated with plate-bound antibodies (5 ug/ml
T3.70 and 50 ug/ml anti-CD28) or with APCs and HY peptide. Cells were
harvested for flow cytometry after 3 d of incubation.
ELISA. Supernatants from the proliferation assays described above were
analyzed by ELISA for the presence of interferon   and IL-2 using reagents
and the protocol from BD Biosciences.
RT-PCR. Thymocytes were stained with anti-CD4 FITC and anti-CD8
PE and were sorted for DP and SP populations using a FACS Vantage SE
cell sorter equipped with TurboSort (Becton Dickinson). RNA was pre-
pared from sorted populations using TriZol reagent (Invitrogen). cDNA
was synthesized using the SuperScript cDNA synthesis system (Invitrogen).
Dilutions of cDNA were made and tested so that amounts used for PCR
were in the linear range. Primers for CD3  were (sense) CTGAGAGGAT-
GCGGTGGAACA and (antisense) GACCATCAGCAAGCCCAGAGT.
PCR conditions for CD3  were 95 C for 5 min and 30 cycles of 95 C for
45 s, 56 C for 45 s, and 72 C for 1 min. Primers for perforin were (sense)
CAAGCAGAAGCACAAGTTCGT and (antisense) CGTGATAAAGT-
GCGTGCCATA. PCR conditions for perforin were 95 C for 5 min and
30 cycles of 95 C for 45 s, 50 C for 45 s, and 72 C for 1 min.
Calcium flux experiments. Measurements of calcium flux were per-
formed essentially as described previously (41). Thymocytes or lymph node
cells were stained for CD4 and CD8 and preloaded with indo-1 (Molecular
Probes). At 30 s, biotinylated anti-CD3 and anti-CD8 (10  g each) were
added and at 60 s, 25  g streptavidin was added. Calcium flux, measured as
the ratio of FL5 to FL4, was recorded on an LSR I (Becton Dickinson) and
is displayed as a function of time.
Phospho-Erk assays. Measurement of levels of phospho-Erk was per-
formed using a modification of the protocol of Priatel et al. (42). 2   106
cells were stimulated by the addition of biotinylated anti-CD3 and anti-
CD8 (10 ug/ml) followed by the addition of 20 ug/ml streptavidin and in-
cubation at 37 C for the indicated times. Reactions were stopped by the
addition of an equal volume of 4% paraformaldehyde followed by cold
methanol fixation (43). Cells were stained with 3 ug/ml anti–p-Erk (no.
9106S; Cell Signaling Technology) followed by staining with goat anti–
mouse Ig-PE, anti-CD4 PerCP, and anti–Thy 1.2 APC (BD Biosciences).
Flow cytometry was performed using a FACSCalibur and CELLQuest soft-
ware (Becton Dickinson). Induction of phospho-Erk could be blocked by
the addition of 10 uM MEK inhibitor U0126 (Calbiochem).
Online supplemental material. Fig. S1 shows diminished calcium flux
in DP thymocytes from female HY  SM88m/m RAG-2 /  mice. Fig. S2
shows the cell surface expression of T3.70, CD24 (HSA), CD69, and  7 in-
tegrin on DP thymocytes, CD8 SP thymocytes, and CD8  lymph node T
cells from HY  LAT /  RAG-2 /  female and HY  LAT Y136Fm/m RAG-
2 /  male mice. Figs. S1 and S2 are available at http://www.jem.org/cgi/
content/full/jem.20041869/DC1.
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